1-888-123-4567

  • THE ERA OF THE MICROBIOME

    En-Biome is a precision microbiome company with a robust screening platform for a continuous pipeline of products of therapeutic value, selectively for either prescription or non-prescription path to market

  • A MODEL APPROACH TO MICROBIOME THERAPEUTICS

    En-Biome screen the microbiome library in germ-free C. elegans disease models followed by disease models in rodents. The selected strain can then be genetically screened by random mutation to identify the key active ingredients

  • PRECISION MICROBIOME

    Our understanding of the role of the microbiota is at the individual microbial strain level. We discover the molecular underpinnings of microbiome-host interactions. The lead strains can be used individually or in combination for a given disease application

EnBiome is a confluence of three key facets that catalyze the success of a innovation driven biotherapeutic startup:
  • thorough understanding of the basic biology
  • extensive experience in developing a lab lead to a successful drug
  • entrepreneurial passion wisened by success
PROPRIETARY SCREENING PLATFORM

Proprietary screening platform exclusively licensed from MGH (Harvard Medical School).

Library of over 1500 bacterial strains and 25 different C. elegans screening models. Our C elegans models express human genes or mutations, mimicking a true germ-free platform.

Learn More

PIPELINE ADDRESSING UNMET NEEDS

NEUROBIOTXTM
neurodegenerative disorders

GUTBIOTXTM
inflammatory bowel disease

SKINBIOTXTM
hyperimmunity driven skin conditions

Learn More

TEAM PRECISELY EXPERIENCED FOR SUCCESS

Basic research out of harvard medical school’s mass general hospital
Co-Founded by pedigreed scientists working on the company's microbiome foundation since 2014.
Management with biotech startup, scaleup, restructuring and strategic exit experience

Learn More

Contact Us

Lexington, MA 01731
617-555-5555